SJ

Sazmabanu Jikarbhai Khatri

Active Director Director DIN 11099823
DIN 11099823 First appointment May 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Sazmabanu Jikarbhai Khatri

Data last updated:

Sazmabanu Jikarbhai Khatri is a Director at Shapion Lifesciences Private Limited (since 2025). The company operates in Pharma.

DIN 11099823
Primary Designation Director
Industry Pharma
First Appointment 09 May 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Shapion Lifesciences Private Limited U21003GJ2025PTC162757
Director09 May 20252025Active

Board colleagues of Sazmabanu Jikarbhai Khatri

NameDINCompanyDesignation
Parth Rameshbhai Jethava11099824Shapion Lifesciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Shapion Lifesciences Private Limited
Premium access

Shareholding and investment profile for Sazmabanu Jikarbhai Khatri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sazmabanu Jikarbhai Khatri

Sazmabanu Jikarbhai Khatri currently holds 1 directorship: Shapion Lifesciences Private Limited (Director, since 09 May 2025).

Sazmabanu Jikarbhai Khatri was first appointed on 09 May 2025 as Director at Shapion Lifesciences Private Limited.

The current boards of Sazmabanu Jikarbhai Khatri's companies include Parth Rameshbhai Jethava (Shapion Lifesciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available